Cryotherapy Has No Significant Effect on MMP-9 anTGF-β1 Expression in Fungal Corneal Ulcer

Dwita Permatasari, Hendrian Dwikoloso Soebagjo, Ismi Zuhria, Nila Kurniasari, Hari Basuki Notobroto, Cinintha Nandini

Abstract


BACKGROUND: Usually, surgical intervention is needed to eradicate the fungal microorganism that cause fungal corneal ulcers. However, since surgical intervention is invasive, the latest technology uses cryotherapy in treating it. Cryotherapy plays a vital role in the wound healing process. We aimed to evaluate is to study the decreased expression of matrix metalloproteinase 9 (MMP-9) and transforming growth factor β1 (TGF-β1) in fungal corneal ulcers after the administration of cryotherapy.

METHODS: Aspergillus flavus fungus was injected to the intrastromal corneas of all Sprague Dawley rats. The rats were divided into four groups, the first group was not given any therapy, the second group was given topical natamycin therapy, the third group was given cryotherapy, and the fourth group was given a combination between cryotherapy and topical natamycin therapy. Therapy was given after five days of follow up on the formation of a corneal ulcer. After four days of therapy, the eyes were enucleated to determine MMP-9 and TGF-β1 expression.

RESULTS: The result in the third group showed lower MMP-9 expression (20.0±10.0% cells per field of view) compared to the second group (40.0±20.0% cells per field of view) and the fourth group (30.0±25.0% cells per field of view), but had the same MMP-9 expression value as the first group. There was no significant difference in MMP-9 expression between the four groups (p=0.356). The third group reduced more TGF-β1 expression (10.0±12.50% cells per field of view) compared to the fourth group (30±27.5% cells per field of view) and the first group (30±32.5% cells per field of view). There was also no significant difference in TGF-β1 between the four groups (p=0.315).

CONCLUSION: There is no significant difference in the expression of TGF-β1 and MMP-9 after the cryotherapy treatment.

KEYWORDS: corneal ulcer, cryotherapy, MMP-9, TGF-β1


Full Text:

PDF

References


Leal Jr SM, Pearlman E. The role of cytokines and pathogen recognition molecules in fungal keratitis–insights from human disease and animal models. Cytokine. 2012; 58: 107–11, CrossRef.

Ansari Z, Miller D, Galor A. Current thoughts in fungal keratitis: diagnosis and treatment. Curr Fungal Infect Rep. 2013; 7: 209–18, CrossRef.

Zhang Y, Liang Q, Liu Y, Pan Z, Baudouin C, Labbé A, et al. Expression of cytokines in aqueous humor from fungal keratitis patients. BMC Ophthalmol. 2018; 18: 105, CrossRef.

Sharma VK, Khandpur S. Guidelines for cryotherapy. Indian J Dermatology, Venereol Leprol. 2009; 75: 90–100, article.

Chen Y, Yang W, Gao M, Belin MW, Yu H, Yu J. Experimental study on cryotherapy for fungal corneal ulcer. BMC Ophthalmol. 2015; 15: 29, CrossRef.

Ramos GV, Pinheiro CM, Messa SP, Delfino GB, de Cássia Marqueti R, de Fátima Salvini T, et al. Cryotherapy reduces inflammatory response without altering muscle regeneration process and extracellular matrix remodeling of rat muscle. Sci Rep. 2016; 6: 18525, CrossRef.

Vemuganti GK, Murthy SI, Das S. Update on pathologic diagnosis of corneal infections and inflammations. Middle East Afr J Ophthalmol. 2011; 18: 277–84, CrossRef.

Sharma N, Vajpayee RB. Corneal Ulcers: Diagnosis and Management. New Delhi: Jaypee Brothers Medical Publisher; 2008.

Avunduk AM, Beuerman RW, Varnell ED, Kaufman HE. Confocal microscopy of Aspergillus fumigatus keratitis. Br J Ophthalmol. 2003; 87: 409–10, CrossRef.

Castano G, Elnahry AG, Mada PK. Fungal Keratitis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021, NLMID.

Leema G, Jayaraman Kaliamurthy PG, Thomas PA. Keratitis due to Aspergillus flavus: Clinical profile, molecular identification of fungal strains and detection of aflatoxin production. Mol Vis. 2010; 16: 843–54, PMID.

Dong X, Shi W, Zeng Q, Xie L. Roles of adherence and matrix metalloproteinases in growth patterns of fungal pathogens in cornea. Curr Eye Res. 2005; 30: 613–20, CrossRef.

Mulholland B, Tuft SJ, Khaw PT. Matrix metalloproteinase distribution during early corneal wound healing. Eye. 2005; 19: 584–8, CrossRef.

Li Q, Gao XR, Cui HP, Lang LL, Xie XW, Chen Q. Time-dependent matrix metalloproteinases and tissue inhibitor of metalloproteinases expression change in fusarium solani keratitis. Int J Ophthalmol. 2016; 9: 512–8, CrossRef.

Tandon A, Tovey JCK, Sharma A, Gupta R, Mohan RR. Role of transforming growth factor Beta in corneal function, biology and pathology. Curr Mol Med. 2010; 10: 565–78, CrossRef.

Takagi R, Fujita N, Arakawa T, Kawada S, Ishii N, Miki A. Influence of icing on muscle regeneration after crush injury to skeletal muscles in rats. J Appl Physiol. 2011; 110: 382–8, CrossRef.

Darisipudi MN, Allam R, Rupanagudi KV, Anders HJ. Polyene macrolide antifungal drugs trigger interleukin-1β secretion by activating the NLRP3 inflammasome. PLoS One. 2011; 6: e19588, CrossRef.

Liu Y, Li C, Yin H, Zhang X, Li Y. NLRP3 inflammasome: a potential alternative therapy target for atherosclerosis. Evid Based Complement Altern Med. 2020; 2020: 1561342, CrossRef.

Wang W, Wang X, Chun J, Vilaysane A, Clark S, French G, et al. Inflammasome-independent NLRP3 augments TGF-β signaling in kidney epithelium. J Immunol. 2013; 190: 1239–49, CrossRef.

Chidambaram JD, Kannambath S, Srikanthi P, Shah M, Lalitha P, Elakkiya S, et al. Persistence of innate immune pathways in late stage human bacterial and fungal keratitis: results from a comparative transcriptome analysis. Front Cell Infect Microbiol. 2017; 7: 193, CrossRef.




DOI: https://doi.org/10.18585/inabj.v13i3.1516

Indexed by:

                 

                  

               

     

 

The Prodia Education and Research Institute